COVID-19 – Caution recommended from AHA, ACC & HRS on COVID-19 treatment with hydroxychloroquine and azithromycin
SPCN wants to be a resource to you during these incredibly difficult times by providing some helpful references and web site links. This reference is particularly important for the safety of some of our patients. Our hope is to provide information that helps you, your patients, and their families. We are honored to be your colleagues and thank you for all that you do in providing care. Please be safe.
Caution recommended on COVID-19 treatment with hydroxychloroquine and azithromycin for patients with cardiovascular disease – Guidance from the American Heart Association, the American College of Cardiology and the Heart Rhythm Society https://newsroom.heart.org/news/caution-recommended-on-covid-19-treatment-with-hydroxychloroquine-and-azithromycin-for-patients-with-cardiovascular-disease-6797342
If you have comments or experiences you would like to share with SPCN News please email gfosse@med.umich.ed. Thank you, SPCN Board
COVID-19 RESOURCES – LIST FOR SPCN MEMBER – 3/28/2020
(disclaimer – NOT an all-inclusive list. Thanks to Dr. Katie Salciccioli for submitting the references and monitoring the literature)
COVID-19 References
- Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
- Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019
- Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19
- BCCA COVID-19 guidance for Vulnerable groups with congenital heart disease (18 March 2020)
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China _ SpringerLink
- CHPHC CHD Information on Coronavirus Disease 2019